Back
Greystone Housing Impact Investors LP Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
32
GHI
Greystone Housing Impact Investors LP
Last Price:
$11.41
Seasonality Move:
-0.87%
Buy
55
RYTM
Rhythm Pharmaceuticals
Last Price:
$59.94
Seasonality Move:
84.98%
Sell
32
Greystone Housing Impact Investors LP (GHI)
is a Sell
Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?
-
The current Greystone Housing Impact Investors LP [GHI] share price is $11.43. The Score for GHI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
GHI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $59.93. The Score for RYTM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GHI Stock Price Chart
What is Greystone Housing Impact Investors LP's stock price today?
-
The Greystone Housing Impact Investors LP share price today is $11.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GHI is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $59.93The current trend is relatively stagnant and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
GHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 45.38 | Sell |
Chaikin Money Flow: | -16192 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.25 - 11.91) | Sell |
Bollinger Bands (100): | (11.2 - 12.66) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 50.09 | Buy |
Chaikin Money Flow: | -502753 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.96 - 63.98) | Sell |
Bollinger Bands (100): | (53 - 60.88) | Buy |
GHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.5 | Sell |
20-day SMA: | 11.65 | Sell |
50-day SMA: | 12 | Sell |
200-day SMA: | 12.46 | Sell |
8-day EMA: | 11.54 | Sell |
20-day EMA: | 11.63 | Sell |
50-day EMA: | 11.83 | Sell |
200-day EMA: | 12.63 | Sell |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.48 | Buy |
20-day SMA: | 61.6 | Sell |
50-day SMA: | 57.19 | Buy |
200-day SMA: | 54.45 | Buy |
8-day EMA: | 59.74 | Buy |
20-day EMA: | 60.24 | Sell |
50-day EMA: | 58.73 | Buy |
200-day EMA: | 53.87 | Buy |
Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.22 per share, an increase this year of $0.11 per share, and an increase next year of $0.37 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Greystone Housing Impact Investors LP Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |